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ABSTRACT
Chronic inflammation can lead to insulin resistance in obesity. Increased mRNA expression 
of inflammatory markers such as toll-like receptor 4 (TLR4) and interleukin 6 (IL6) were 
reported both in the tissue and the peripheral blood of obese adolescent and correlated 
with insulin resistance. DNA methylation surrounding TSS region is known to regulate the 
level of a gene expression. The aim of the study was to investigate the methylation status 
of TLR4 and IL6 promoter in peripheral blood of obese adolescent and its correlation to 
insulin resistance. This was a cross sectional study with observational analytic approached. 
Fifty adolescents with obesity from Yogyakarta Special Region, aged 15-18 years, 
z-score value >2 SD, no experience of any acute infections within 2 weeks and signed in 
informed consent, were selected in this study. Subjects with diabetic mellitus, incomplete 
data and DNA concentration of <20 µg/mL were excluded. DNA samples were extracted 
from peripheral blood of the subjects. The bisulfite converted DNA was analyzed for 
methylation level with direct sequencing. Correlation analysis using Spearman test was 
performed with significance value was set at p<0.05. No methylation in TLR4 promoter 
was detected in all subjects. The methylation level of IL6 was transformed to categorical 
variable. Four (8%) subjects with insulin resistance and 2 (4%) without insulin resistance 
had methylation on a CpG site. Methylation of IL6 was not statisticaly different between 
insulin resistance and non-resistance adolescent (p=0.635). The significant correlation 
was not found between methylation level in IL6 promoter with insulin resistance (HOMA-
IR) (r=0.051). Cell specific of methylation mechanism, characteristic of subjects and 
types of samples were suspected causing those results. In conclusion, no correlation 
between methylation levels of TLR4 promoter and IL6 with insulin resistance in obese 
adolescent was observed in this study. 
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ABSTRAK
Inflamasi kronis dapat menyebabkan resistensi insulin pada obesitas. Peningkatan ekspresi 
mRNA pada penanda inflamasi seperti toll-like receptor 4 (TLR4) dan interleukin 6 (IL6) 
dilaporkan terjadi di jaringan dan darah tepi pada remaja obes dan berhubungan dengan 
resistensi insulin. Metilasi DNA di sekitar regio Transcriptional Start Site (TSS) berperan 
pada pengaturan ekspresi gen. Penelitian ini bertujuan untuk mengkaji status promoter TLR4 
dan IL6 darah tepi remaja obes dan hubungannya dengan resistensi insulin. Rancangan 
studi potong lintang dengan pendekatan analitik observasional digunakan pada penelitian 
ini. Penelitian melibatkan 50 remaja obes di Daerah Istimewa Yogyakarta (DIY), berumur 
15-18 tahun, mengalami obesitas dengan skor z >2 SD, tidak memiliki riwayat infeksi 
akut selama 2 minggu terakhir dan menandatangani surat pernyataan persetujuan keikut 
sertaan dalam penelitian. Kriteria eksklusi adalah subjek dengan diabetes mellitus, data tidak 
lengkap, dan konsentrasi DNA <20 µg/mL. Sampel DNA diekstraksi dari darah tepi untuk 
selanjutnya dikonversi dengan bisulfit, dan dianalisis untuk mengetahui tingkat metilasi 
dengan sekuensing DNA secara langsung. Analisis statistik dilakukan menggunakan uji 
korelasi Spearman dengan nilai kemaknaan p<0,05. Hasil penelitian menunjukkan bahwa 
metilasi pada promoter TLR4 tidak terdeteksi pada seluruh subjek. Tingkat metilasi IL6 
diubah menjadi variabel kategorik. Empat (8%) subjek dengan resitensi insulin dan 2 
(4%) subjek sensitif insulin menunjukkan metilasi pada sisi CpG. Metilasi pada IL6 secara 
statistik tidak menunjukkan adanya perbedaan bermakna antara remaja dengan resistensi 
insulin dan sensitif resistensi (p=0.635). Tidak ada hubungan antara tingkat metilasi 
promoter IL6 dengan resistensi insulin (HOMA-IR) (r=0.051). Mekanisme metilasi spesifik 
sel, karakteristik subjek dan tipe-tipe sampel diduga berpengaruh terhadap hasil yang 
diperoleh pada penelitian ini. Kesimpulan dari penelitian ini adalah tidak adanya hubungan 
antara tingkat metilasi promoter TLR4 dan IL6 dengan resistensi insulin pada remaja obes. 
INTRODUCTION
Indonesia has been included in top 10 
countries with the highest prevalence of 
obesity in the world.1 The prevalence of obese 
adolescent in Indonesia increased from 1.4% 
in 2007 to 7.3% in 2013.2 Around 5.7 % 
adolescents aged 16-18 years is overweight, 
while 1.6 % is included in the category 
of obese.2 Yogyakarta Special Region is a 
province in Indonesia that has the highest 
prevalence of adolescent obesity in 2010 
and as one of the cities where the prevalence 
of obese adolescent prevalence above the 
national average in 2013.2,3
Obesity at a young age will give long-
term health impacts, for example the tendency 
of being obese in adulthood, increasing the 
risk of developing degenerative diseases 
such as type 2 diabetes mellitus (T2DM), 
hypertension, ischemia and stroke, until a 
decline in life expectancy (life expectance).4-6 
Insulin resistance (IR) is one of major factors 
which cause T2DM manifestation. The level 
of IR by homeostatic model assessment-
insulin resistance (HOMA-IR) is known 
having linear correlation with body mass 
index (BMI) and fat deposition percentage in 
adolescent.7
Inflammation is the most studied pathway 
to explain individuals with obesity may 
develop to insulin resistance. This pathway 
includes inflammatory activation through 
toll-like receptor 4 (TLR4) and interleukin 
6 (IL6). The pro-inflammatory enzymes 
activated either by of TLR4 or IL6 may 
interfere insulin signaling transduction by 
targeting insulin receptor substrate (IRS).8-10 
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of biochemical parameters. The remaining 
precipitate including buffycoat were stored in 
4oC until used. In this study, 50 obese subjects 
followed by the data such as fasting glucose 
blood (mg/dL), insulin level (mg/dL) and 
HOMA-IR were chosen by random sampling 
with sex stratification from the previous study. 
This study was approved by the Medical and 
Health Research Ethics Committee of the 
Faculty of Medicine, Universitas Gadjah 
Mada, Yogyakarta.
Obese adolescent were defined according 
to Indonesia Basic Health Research (2013) 
and WHO (2007) as those having z-score of > 
2. Insulin resistance were defined as HOMA-
IR > 3.2.17 Fasting blood glucose ≥ 126 mg/
dl was defined as T2DM.2 Value of HOMA-
IR > 3.2 was defined as insulin resistance. 
Methylation level of each subject was defined 
as an average of methylation level of all CpG 
in target region based on chromatogram from 
sequencing results. Methylation level of each 
CpG was calculated by Lewin’s equations.18
DNA extraction and bisulfite treatment
Genomic DNA was extracted by DNA 
genomic Promega Wizard® Genomic DNA 
Purification Kit. Four hundred nanogram of 
genomic DNA was used for bisulfite treatment 
according to the procedure of EZ - methylation 
Zymo Gold Kit with a total elution volume of 
10 mL and stored at -20°C.
Amplification of target region 
Region target of IL6 at -290 to +10 
was amplified using primer forward 
AGTTATTAATAAAAGAAAAA-3’ and 
reverse 5’- ACAAAATAAACCTCAA-
ACATCTC-3’. While primer for TLR4 
amplification were forward 5’-GTTTTTTT-
AGTTATTGGTTTGTAGG-3’ and reverse 5’- 
AAACAAACATCATCCTAACATCATC-3’ 
which is targeting region at -94 to +202. 
Cycling condition for amplification of IL6 
The increase of expressing gene of TLR4 and 
IL6 has been reported in obese and T2DM.11,12 
This increase mainly occur in insulin targeting 
cells such as adipocytes, hepatocytes, and 
skeletal muscle cells.13-15 One of mechanisms 
which regulate the level of gene expression 
is DNA methylation. Although the status and 
level of methylation is specific to each type 
of cell but the increase of mRNA TLR4 and 
IL6 has been reported in polymorphnuclear 
cell of individuals with obesity and positively 
correlates with insulin resistance.11,16 It has 
been suggested that there is DNA methylation 
regulation which cause such increase. How-
ever, there was no report about the status of 
promoter methylation of IL6 and TLR4 with 
IR in obese adolescent’s peripheral blood. 
This study aims to investigate how the level of 
the status of promoter methylation of IL6 and 
TLR4 in obese adolescent and its correlation 
with insulin resistance. 
MATERIALS AND METHODS
Subjects 
Samples of this study was a part of 
samples from the study conducted by Huriaty 
in 2014 (unpublished). In the previous study, 
4000 adolescents from 10 senior high schools 
in Yogyakarta Special Region followed 
screening tests such as height (cm) and 
weight (kg) for grouping by nutritional status. 
Following the exclusion of subjects with the 
history of T2DM and kidney diseases, as many 
as 263 adolescents, aged 15-18 years, was not 
having any infection in 2 weeks (confirmed 
by questionnaire and medical examination by 
doctor), and both of parents and adolescents 
signed the informed consent, enrolled in the 
present study as subjects. Blood samples were 
collected following 10-12 fasting overnight in 
tube containing EDTA. The collected blood 
were centrifuged to separate its composition. 
Blood plasma were used for measurement 
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resistance. The data were then grouped based 
on the status of insulin resistance by gender 
stratification to analyse the mean difference 
between groups.
were 95oC for 5 minutes, 50 cycle of 95oC 
for 1 minute, 55oC for 1 minute dan 72oC for 
1 minute 50 and final extension for 5 minute 
at 72oC. Similar cycling condition was used 
for TLR4 amplification except for annealing 
temperature was 60oC for 1 minute. The PCR 
product was stored at 4oC until being used. 
Primer used in this study was designed using 
Meth Primer.19
Direct sequencing
Thirthy microliter of PCR product and 10 
µl sent to 1st base to be sequenced by Sanger 
method. Sequencing of IL6 used forward 
primer whereas TLR4 used reverse primer. 
PCR clean-up and sequencing protocol was 
done according to daily protocol of 1st base.
Statistical analysis
Data were presented as mean ± standard 
deviation (SD) or as median (minimum-
maximum) depending on the types of data. 
The mean difference between groups was 
tested using unpaired t-test. Correlation 
analysis between methylation of TLR4 and 
IL6 promoter was performed using Spearman 
test. The differences between groups were 
considered statistically significant if a p value 
< 0.05. 
RESULTS 
The chracteristics of subject are presented 
in TABLE 1. Fifty 50 adolescents with obesity 
consisting of 25 (50%) male and 25 (50%) 
female from Yogyakarta Special Region 
were involved in this study. The mean age of 
subjects was 16.77±0.72 years. Z -score value 
mean obtained based on the WHO criteria 
was 3.8±0.97. Median level of fasting blood 
glucose, insulin and HOMA-IR values, were 
84.5 (68.0-13.0), 19.28 (7.08-52.96) and 
4.35 (1.7-10.1), respectively. A total of 68 % 
of the total subjects in this study had insulin 
TABLE 1. Subject characteristics
Variables Value (n=50)
Sex
•	 Male 25 (50%)
•	 Female 25 (50%)
Age (years) 16.77 ± 0.72a
Z-Score 3.8 ± 0.97a
FBG (mg/dL) 84.5 (68.0 – 113.0)b
Insulin (µIU/mL) 19.28 (7.08 – 52.96)b
HOMA-IR 4.35 (1.7 – 10.1)b
Non-Insulin resistance 
(Non-IR) 16 (32%)
Insulin resistance (IR) 34 (68%)
a Presented in mean ± standard deviation (SD)
b Presented in median value (minimum-maximum)
Mean difference of age and z-score was 
performed using unpaired t-test whereas 
FBG level, insulin level, and HOMA-IR was 
performed using Mann Whitney test. The age 
of subjects was similar across groups. Z-score 
values and FBG level was significantly 
different within female between the insulin 
resistance and non-insulin resistance groups 
(p<0.05) but not in boys. Levels of insulin and 
HOMA-IR values were significantly higher in 
insulin resistance group in both female and 
male (p < 0.001) (TABLE 2).
Amplification of bisulfite coverted DNA
FIGURE 1a and 1b show that the 
amplification of bisulfite -modified DNA (Bis 
- DNA) of gene promoter target region of IL6 
and TLR4 was successfully performed. It was 
characterized by an intense single band on 
2% agarose gel that is at 300bp for IL6 and 
296 bp for TLR4 compared to DNA marker. 
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TABLE 2. Mean difference between groups
Category
Female Male
IR
(n=18)
Non-IR
(n=7)
IR
(n=16)
Non-IR
(n=9)
Agea 16.78 ± 0.7 16.68 ± 0.7 16.65 ± 0.6 17.02 ± 0.9
Z-scorea 4.2 ± 0.9 3.16 ± 0.6* 3.74 ± 1.0 3.51 ± 1.0
FBGb (mg/dL)
86.5
(73-113)
77*
(68-90)
87.5
(74-111)
76
(69-101)
Insulinb (mg/dL)
25.53
(16.85-40.19)
14.94**
(9.62-18.41)
22.18
(16.21-52.96)
13.33**
(7.08-16.99)
HOMA-IRb
5.15
(3.8 - 9.2)
2.9**
(1.7-3.1)
4.9
(3.4-10.1)
2.5**
(1.7 - 3.1)
a Presented in mean ± standard deviation (SD)
b Presented in median value (minimum-maximum)
* Significance p<0.05
**Significance p<0.001
FIGURE 1.  Bisulfite-modified DNA (Bis-DNA) amplicon visualization of the target region 
of IL6 and TLR4 gene promoter on 2% agarose gel.
Sequencing was performed to confirm that the 
region amplified by the primer was a target 
region. The nucleotide sequences obtained 
from sequencing was aligned to compare with 
DNA sequences from NCBI using Multalin. 
The results show that the alignment of the 
amplified region is equal to the target region 
with nucleotide similarities 90 %.
Direct Bisulfite Sequencing PCR TLR4
DNA conversion was successful (FIGURE 
2). It was shown from the sequence that more 
than 90 % C non-CpG nucleotide turned into 
a T nucleotide. The electrogram also did 
not show any background noise that could 
interfere the calculation of the percentage of 
methylation per CpG.
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The results of TLR4 promoter region -94 
to +202 sequencing showed that the entire 
nucleotide C of predicted CpG changed into 
nucleotides T except on CpG1. Cytosine of 
CpG1 (based on reference sequence) was read 
as guanine in chromatogram. It indicates that 
the entire targeted CpG in the target region was 
unmethylated. The percentage of methylation 
also could not be calculated because no 
overlapping found between nucleotides C and 
T in the predicted CpG. 
Targeted IL6 promoters in this study 
were around -290 to +10 nucleotides of TSS 
that includes 5 CpGs (FIGURE 3). Several 
overlapping peak between nucleotide C peak 
and nucleotide T was found in predicted CpG 
site of IL6 electrogram. Peak ratio between 
them was calculated using Lewin’s equation 
to get methylation level of each CpG.
FIGURE 2.  Electrogram of target region of TLR4 gene promoter. Region target 
arround at -94 to +202 of the TSS that include 7 CpG . There was no 
methylation found in all CpG of region target which is characterized by 
the entire nucleotide C in CpG turned into a nucleotide T.
FIGURE 3. Electrogram of one of IL6 CpG in target 
region. Methylation level was obtained by 
calculating the ratio of peak height on C (blue) 
and T (red).
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Only 6 from 50 subjects showed 
methylation in the promoter IL6 (FIGURE 4) 
. The level of methylation in IL6 target region 
obtained in the study were very low, ranging 
from 0 to 12.91%. The analysis was performed 
TABLE 3. Fisher test of methylation of IL6 between IR and non-IR group
Methylation Status  IR (n=34) Non-IR (n=16) RR (CI95%) p
Methylated 4 2 0.978(0.536- 1.783)
> 0.05
Unmethylated 30 14
1.023
(0.561- 1.865)
Among methylated group, 4 (8% ) subjects 
was insulin resistance while 2 (4%) subjects 
was non-insulin resistance. Relative risk of 
methylated group being insulin resistance 
was lower (RR=0.978) compared with 
unmethylated group (RR=1.023). However 
the risk was not statistically different between 
groups ( p > 0.05).
Correlation analysis by Spearman 
test showed that there was no statistically 
using different proportions of methylation 
level data that has been transformed into a 
categorical variable. Subjects who showed 
any methylation minimal at one CpG would 
be categorized as methylated group (TABLE 
3).
FIGURE 4. Distribution of methylation level. Only 6 out of 50 
subjects showed any methylation with low level of 
methylation.
significant correlation found between 
methylation level and HOMA-IR neither 
with z-score, FBG level and insulin level. 
Significant positive correlation was shown 
between z-score and insulin level as well 
as z-score and HOMA-IR but z-score and 
FBG level was not correlated significantly 
(r=0.123). FBG levels with insulin levels 
(r=0.078) and HOMA-IR values (r=0.325) 
also showed a positive correlation, but only 
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correlation between FBG level and HOMA - 
IR was statistically significant. Strong positive 
correlation was shown between insulin level 
and HOMA-IR. Significant correlation was 
found between insulin level and HOMA-IR 
(r=0.949) (TABLE.4).
Variables Z-Score FBG Insulin HOMA-IR
Methylation level
     r -0.085 0.056 -0.009 0.051
     p 0.279 0.350 0.477 0.362
Z-Score
     r 0.158 0.301* 0.301*
     p 0.137 0.017 0.017
FBG
     r 0.078 0.325*
     p 0.295 0.011
Insulin
     r 0.949**
     p 0.000
TABLE 4. Correlation between variables
DISCUSSION
Our data show that a total of 68 % of the 
subjects in this study had insulin resistance 
(TABLE 1). These data confirm the results 
of the previous research that reported that 
more than a half of the population of children 
and adolescents with obesity have insulin 
resistance.20 The median value of insulin levels 
in this study was 19.28 μIU/mL with the range 
of insulin levels obtained was between 7.08 
to 52.96 μIU/mL (TABLE 1). Although the 
value limit of normal insulin levels in previous 
studies showed varying results, insulin levels 
in the present study were higher than the cut-
off range of hyperinsulinemia in adolescents 
aged 14-19 years which was 18.15 to 23.73 
μIU/mL.21 A study by Rodriguez-Moran et 
al.,22 used 16 μIU/mL for hyperinsulinemia 
cut-off category in adolescents.22 A study 
of cardiovascular disease in children and 
adolescents by the American Heart Association 
(AHA) established that insulin levels by 15-20 
μIU/mL as a borderline high of insulin normal 
levels.23
A significant difference occurred between 
the value of HOMA-IR in the insulin resistance 
group and the non-insulin resistance both 
group. High value of HOMA-IR in this study 
was probably to be more influenced by insulin 
levels rather than FBG. This is supported by 
the relatively weak results of correlation test 
between the levels of FBG and HOMA-IR 
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compared to insulin and HOMA-IR (TABLE 
4). Hyperinsulinemia in adolescents has 
been reported to be a physiological condition 
which is affected by growth hormone and 
an increasing body mass during puberty.24 
Insulin secretion will return to normal 
level by the end of puberty.25 However, the 
condition of hyperinsulinemia accompanied 
by obesity during adolescence may increase 
the risk of insulin resistance which is known 
as a major factor related to cardiovascular 
disease and type 2 diabetes.23 Low-grade 
chronic inflammation and imbalance levels of 
adipokines in obesity conditions may interfere 
insulin signal transduction which decreases 
glucose uptake by cells. The decrease of 
glucose uptake by cell results in increasing 
pancreas secretion of insulin as an effort to 
increase glucose uptake in order to keep blood 
glucose at normal level.
The degree of insulin resistance has been 
reported to be linear to BMI and body fat 
percentage.7 Insulin resistance in obesity is 
associated with metaflamation or inflammatory 
response that occurs as a result of excessive 
nutrients consumption.26 Free fatty acids, 
which is reported to be increasing in condition 
of obesity, are one of inducing factor for 
inflammatory response through TLR-4.13,14,27,28 
Proinflammatory enzymes such as JNK and 
IĸKβ which are active in downstream TLR-
4 signaling can lead to impaired insulin 
signaling through phosphorylation at IRS 1 
serine residues.8 Cytokine IL-6, one of the 
proinflammatory cytokine which is secreted 
through TLR-4 signals, can also cause the IRS 
as an adapter protein loses its’ function. SOCS3 
which is active in IL-6 signal transduction, is 
able to decrease the phosphorylation of IRS 
1 and even increase the ubiquitilation of IRS 
1 and subsequently affect the insulin signal 
transduction.9,10 These cellular mechanisms 
not only cause chronic inflammatory 
conditions continue to occur, but also interfere 
insulin signaling, and thus the glucose uptake 
will be impaired. A decrease in glucose uptake 
will lead to the increase of insulin secretion 
induction.
Although all subjects were obese, 
mean difference test results showed that the 
z-score value affects the incidence of insulin 
resistance in adolescent girls but not in boys 
(p <0.05) (TABLE 2). Level of FBG was 
also significant in girls group only. Insulin 
resistance in boy adolescent may occur by 
hormonal effect on the balance of adipokines. 
Adiponectin level was reported to decrease 
in obese condition. During puberty in male 
adolescents, adiponectin levels decrease 
with increasing testosterone and negatively 
correlate with HOMA-IR.29
Promoter methylation levels of TLR4 
and IL6 in this study were detected using 
direct-BSP methods and were analyzed 
with Lewin’s equation. The present study 
targetted ±300 bp promoter region of the 
TSS. Differences of distance between the 
methylated region with the transcription start 
site (TSS) order is known to be affecting the 
expression level. Methylation around TSS 
such as exon one, and downstream promoter 
significantly showed lower genes expression 
than methylation on the upstream promoter 
or intragenic region and last exons.30 A study 
about pattern distribution and methylation 
level has shown that gene with highest 
expression has lower methylation on region 
around 500bp from TSS.31 Target region in 
this study has transcription factor binding 
site as predicted by PROMO software.32 Each 
transcription factor was reported to have a 
role in the regulation of the transcription of 
the gene. 
Based on sequencing of TLR4 promoter 
region around -94 to +202, it was shown 
that all subjects were not methylated in all 
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predicted CpG. As far as our knowledge, no 
studies have reported the methylation level of 
TLR4 on peripheral blood cells adolescents 
with obesity and its correlation with insulin 
resistance. Studies on TLR-4 methylation has 
been performed in intestinal epithelial cells 
and gingival tissue. A study by Takahashi et 
al.,33 using cell intestinal epithelial cell line 
reported that methylation at -69 to +277 serve 
to maintain homeostasis condition of normal 
flora in the digestive tract by emphasizing the 
expression of TLR-4.33 The different results 
between our study and theirs may occur 
because of the characteristic of methylation 
mechanisms itself which are specific to 
each cell.34 Research on TLR4 promoter 
methylation at CpG -646 and -822 positions 
in the gingival tissues showed that almost 
the whole subjects in the regions were not 
methylated and were not associated with TLR-
4 mRNA transcripts.35 Because all subjects 
were not methylated in the region target of 
the TLR4 promoter, it can be concluded that 
there was no correlation between the degree 
of methylation in the TLR4 target region with 
insulin resistance in adolescents with obesity.
Methylation of CpG on the promoter 
region has been known to affect the 
effectiveness of transcription initiation 
complex formation. However, it was reported 
that methylation can also occur in untranslated 
regions, exons, the non-coding region, and 
repetitive sequence although its mechanism 
to influence the transcription process is not 
widely known.36,37 Therefore it is possible 
that epigenetic regulation does not occur in 
the target region but occurs in other regions. 
Remely et al.,38 reported that the gene TLR4 
exon 1 methylation level of intestinal cells 
found in individuals with obesity is lower 
than the control group.38 Methylation in 
exon 1 of a gene affects the transcriptional 
silencing occurence more than the promoter 
methylation in the upstream portion.30 
However, the mechanisms of how gene’s body 
methylation influence the transcription process 
effectiveness is still unknown. Methylation in 
gene’s body is suspected to play a role in the 
splicing process.39
Targeted IL6 promoters in this study are 
inside -290 to +10 nucleotides of TSS that 
includes 5 CpGs (FIGURE 3). The level of 
methylation in IL6 target region obtained in 
the present study are very low, ranging from 0 
to 12.91% and only 6 of the 50 subjects showed 
methylation in IL6 target region (FIGURE 
4) Therefore, the data is transformed into 
categorical form with minimum requirements 
1 of CpGs which shows any methylation is 
categorized as methylated. Fisher test results 
in TABLE 3 shows that the relative risk of 
individuals with methylation on IL6 promoter 
suffering insulin resistance is smaller 
(RR=0.978) compared with individuals who 
were methylated (RR=1.023). However, there 
is no significant difference between the insulin 
resistance with no insulin resistance groups 
(TABLE 3). 
There was no statistically significant 
correlation between the levels of IL6 promoter 
methylation with other variables such as 
z-score, GDP, levels of insulin and HOMA-
IR value. Zhang et al.,40 study showed similar 
results which shows no correlation between 
IL6 promoter methylation with BMI.40 
Different results were reported by Na et al.,41 
which significantly had more IL6 promoter 
hypermethylation in peripheral blood cells 
of women with obesity than overweight 
group or normal BMI group. The occuring 
hypermethylation is suspected as a negative 
feedback to suppress the IL-6 levels on the 
condition of obesity.41
Promoter DNA methylation may 
influence the transcription process by either 
directly inhibits the binding of transcription 
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factors to the binding site or together with 
MBD, histone deacetylase enzyme and 
histone methyltransferase enzyme causing 
modifications of histones. The histone 
modification can cause chromatin structure 
to become more compact and therefore the 
transcription factor binding sites become 
inaccessible and the transcription process 
may also be disrupted. DNA methylation 
mechanism will lead to repression of 
transcription thus decreasing the expression 
of a gene or vice versa.42,43
Methylation around TSS such as exon-1 
and downstream promoter (250bp) results in 
lower gene expression than methylation on 
upstream promoter, intragenic region or last 
exon. Nonetheless, Nile et al.,44 showed that 
methylation on -1099 significantly represses 
the expression of mRNA of TLR4.44 This may 
occur if the methylated CpG is precisely on 
TFBS and affects binding affinity between 
transcription factor and TFBS.45
There are several possibilities of why 
methylation in the TLR4 promoter target 
region was not found and methylation in the 
IL6 target region was in low levels in this 
study. First, every subject in this study was an 
individual with obesity. Obesity is known as a 
condition due to chronic inflammation which 
is characterized by increased expression 
of TLR4 and IL6 not only on the insulin 
target cells, but also on the peripheral blood 
cells.11,12,28 Thus, low levels of methylation of 
IL6 in the target region or even the absence of 
methylation at TLR4 CpG target allegedly is 
indeed an up-regulation form of TLR-4 and 
IL-6 on the obesity condition through DNA 
methylation.
Toll-like receptor 4 in circulation is mainly 
expressed by monocytes which are known to 
secrete IL-6 mostly through the activation of 
TLR-4 in circulation on the obesity condition46 
However, the composition of monocytes is 
only about 2-8% of total leukocytes in the 
circulation.47 The level of obtained methylation 
is also suspected to be very low considering 
that this study used a sample buffycoat and not 
specific mononuclear cells. Other possibilities 
for improvement of IL6 mRNA and TLR4 
were widely reported increases in peripheral 
blood cells of individuals with obesity are not 
regulated by other DNA methylation but by 
other mechanisms such as mRNA stability, the 
effectiveness of the enhancer and suppressor, 
polymorphism influences or the existence of 
miRNA. The weakness of this study is not 
to measure the mRNA of TLR-4 or IL-6, 
therefore it is not known whether there is a 
relationship between the methylation status in 
the studied region with the produced mRNA 
transcripts. Besides, this study did not observe 
the levels of free fatty acids which act as an 
initiator of inflammation through TLR4.
The characteristics of subjects in this 
study had been designed to prevent bias in the 
obtained methylation results by determining 
short age limit which is 15-18 years old and 
making gender stratification. Selection of 
stratification by gender was based on research 
which showed differences in methylation 
levels between men and women; not only in 
the X chromosome, but also in autosomes.48-50 
The influence of age on methylation occurs 
in almost all tissues and healthy cells (non-
cancer) in humans and can be used to predict 
a person’s age in forensic or can be used as a 
routine examination for predicting the risk of 
age-related diseases.51-53
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